Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: A European multicenter study

Neurorehabilitation and Neural Repair

Volumn 28, Issue 7, 2014, Pages 621-631

  Baert, Ilse ^a   Freeman, Jennifer ^b   Smedal, Tori ^c   Dalgas, Ulrik ^d   Romberg, Anders ^e   Kalron, Alon ^f   Conyers, Helen ^g   Elorriaga, Iratxe ^h   Gebara, Benoit ⁱ   Gumse, Johanna ^j   Heric, Adnan ^k   Jensen, Ellen ^l   Jones, Kari ^c   Knuts, Kathy ^m   Maertens De Noordhout, Benoît ⁿ   Martic, Andrej ^o   Normann, Britt ^p   Eijnde, Bert O ^a   Rasova, Kamila ^q   Santoyo Medina, Carmen ^r   Truyens, Veronik ^m   Wens, Inez ^a   Feys, Peter ^a   more..

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d AARHUS UNIVERSITY   (Denmark)

^e Maskun Neurologinen Kuntoutuskeskus   (Finland)

^f SHEBA MEDICAL CENTER   (Israel)

^g POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^h Eugenia Epalza Rehabilitation Center   (Spain)

ⁱ National Multiple Sclerosis Center   (Belgium)

^j Helsinki MS Neuvola   (Finland)

^k Multiple Sclerosis Center Hakadal AS   (Norway)

^l Multiple Sclerosis Rehab Hospital   (Denmark)

^m Multiple Sclerosis and Rehab Center   (Belgium)

ⁿ Centre Neurologique et de Readaptation Fonctionelle   (Belgium)

^o UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^p NORDLAND HOSPITAL   (Norway)

^q CHARLES UNIVERSITY   (Czech Republic)

^r Hospital de Dia de Barcelona   (Spain)

more..

Author keywords

clinically meaningful improvement; multiple sclerosis rehabilitation; responsiveness; walking measures

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; WALKING; WALKING SPEED; CLINICAL TRIAL; CONVALESCENCE; EUROPE; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PHYSIOTHERAPY; STANDARD; STANDARDS; TREATMENT OUTCOME;

ADULT; DISABILITY EVALUATION; EUROPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PHYSICAL THERAPY MODALITIES; RECOVERY OF FUNCTION; REFERENCE STANDARDS; TREATMENT OUTCOME; WALKING;

EID: 84906261642     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/1545968314521010     Document Type: Article

References (36)

1. Heesen C, Böhm J, Reich C, Kasper J, Goebel M, Gold SM. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler. 2008 ; 14: 988-991
2. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001 ; 124 (pt 5). 962-973
3. Larocca NG. Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient. 2011 ; 4: 189-201
4. Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler. 2012 ; 18: 914-924
5. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987 ; 40: 171-178
6. de Groot V, Beckerman H, Uitdehaag BM, et al. The usefulness of evaluative outcome measures in patients with multiple sclerosis. Brain. 2006 ; 129 (pt 10). 2648-2659
7. Filipovic GP, Matijaca M, Lusic I, Capkun V. Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses. Med Sci Monit. 2011 ; 17: CR704 - CR710
8. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology. 2003 ; 60: 31-36
9. Paltamaa J, Sarasoja T, Leskinen E, Wikstrom J, Malkia E. Measuring deterioration in international classification of functioning domains of people with multiple sclerosis who are ambulatory. Phys Ther. 2008 ; 88: 176-190
10. Learmonth YC, Dlugonski DD, Pilutti LA, Sandroff BM, Motl RW. The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis. Mult Scler. 2013 ; 19: 1784-1791
11. Freeman J, Walters R, Ingram W, Slade A, Hobart J, Zajicek J. Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures. Mult Scler. 2013 ; 19: 1632-1639
12. Kragt JJ, van der Linden FA, Nielsen JM, Uitdehaag BM, Polman CH. Clinical impact of 20% worsening on Timed 25-Foot Walk and 9-Hole Peg Test in multiple sclerosis. Mult Scler. 2006 ; 12: 594-598
13. Hoogervorst EL, Kalkers NF, Cutter GR, Uitdehaag BM, Polman CH. The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite. Mult Scler. 2004 ; 10: 55-60
14. Coleman CI, Sobieraj DM, Marinucci LN. Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis. Curr Med Res Opin. 2012 ; 28: 49-56
15. Feys P, Bibby B, Romberg A, et al. Within-day variability of short and long walking tests in persons with multiple sclerosis. J Neurol Sci. :
16. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001 ; 50: 121-127
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1152
18. Gijbels D, Dalgas U, Romberg A, et al. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set. Mult Scler. 2012 ; 18: 364-371
19. Feys P, Gijbels D, Romberg A, et al. Effect of time of day on walking capacity and self-reported fatigue in persons with multiple sclerosis: a multi-center trial. Mult Scler. 2012 ; 18: 351-357
20. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler. 1999 ; 5: 244-250
21. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed). 1982 ; 284: 1607-1608
22. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2008 ; 14: 383-390
23. Guyatt GH, Norman GR, Juniper EF, Griffith LE. A critical look at transition ratings. J Clin Epidemiol. 2002 ; 55: 900-908
24. Gijbels D, Alders G, Van Hoof E, et al. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler. 2010 ; 16: 618-626
25. Haley SM, Fragala-Pinkham MA. Interpreting change scores of tests and measures used in physical therapy. Phys Ther. 2006 ; 86: 735-743
26. Pfennings LE, van der Ploeg HM, Cohen L, Polman CH. A comparison of responsiveness indices in multiple sclerosis patients. Qual Life Res. 1999 ; 8: 481-489
27. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982 ; 143: 29-36
28. Phan-Ba R, Pace A, Calay P, et al. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis. Neurorehabil Neural Repair. 2011 ; 25: 672-679
29. Gremeaux V, Troisgros O, Benaim S, et al. Determining the minimal clinically important difference for the six-minute walk test and the 200-meter fast-walk test during cardiac rehabilitation program in coronary artery disease patients after acute coronary syndrome. Arch Phys Med Rehabil. 2011 ; 92: 611-619
30. Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2010 ; 91: 221-225
31. Smedal T, Myhr KM, Aarseth JH, et al. The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis. Acta Neurol Scand. 2011 ; 124: 45-52
32. Wiles CM, Newcombe RG, Fuller KJ, et al. Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001 ; 70: 174-179
33. Snook EM, Motl RW. Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair. 2009 ; 23: 108-116
34. Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev. 2005 ; (1). CD003980
35. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977 ; 33: 159-174
36. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008 ; 61: 102-109